Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apoptosis induction refers to the initiation of programmed cell death, a tightly regulated process essential for development, tissue homeostasis, and defense against disease. There are two primary molecular pathways: the intrinsic (mitochondrial) and extrinsic (death receptor) pathways. Both converge on activation of effector/executioner caspases that orchestrate cellular breakdown. Regulation occurs through BCL-2 family proteins, decoy receptors, and c-FLIP. Induction of apoptosis serves functions such as removing damaged cells, regulation during development, and defense against viral infection. Failure or dysregulation contributes to diseases such as cancer, autoimmune disorders or degenerative diseases. Many anticancer therapies aim to induce apoptosis selectively in tumor cells.
Activating proapoptotic molecules/caspases directly or inhibiting their natural inhibitors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis Induction.